SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-020541
Filing Date
2021-04-26
Accepted
2021-04-26 16:24:34
Documents
12
Period of Report
2021-04-23
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K rcus-8k_20210423.htm   iXBRL 8-K 31073
  Complete submission text file 0001564590-21-020541.txt   156033

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rcus-20210423.xsd EX-101.SCH 5776
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rcus-20210423_lab.xml EX-101.LAB 18719
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rcus-20210423_pre.xml EX-101.PRE 11175
5 EXTRACTED XBRL INSTANCE DOCUMENT rcus-8k_20210423_htm.xml XML 3419
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Filer) CIK: 0001724521 (see all company filings)

IRS No.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38419 | Film No.: 21854144
SIC: 2834 Pharmaceutical Preparations